|
US2009281114A1
|
|
Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction
|
|
US2009281112A1
|
|
Adatanserin and metabolites thereof for treatment of attention deficit disorder, anxiety, depression, sexual dysfunction, and other disorders
|
|
CN102026639A
|
|
3-hydroxy gepirone for the treatment of attention deficit disorder and sexual dysfunction
|
|
US2006099267A1
|
|
High-dosage extended-release formulation of gepirone
|
|
CA2585606A1
|
|
High-dosage extended-release formulation of gepirone
|
|
US2005095286A1
|
|
Extended release compositions
|
|
AU2003280010A1
|
|
Methods for treating attention deficit disorder
|
|
CN1714791A
|
|
Use of bioactive metabolites of gepirone for the treatment of psychological disorders
|
|
US6534507B1
|
|
Methods for treating psychological disorders using bioactive metabolites of gepirone
|
